ClinicalTrials.gg
Status unknownNCT01509924Updated Sep 16, 2014

Cognitive and Physical Functions in Patients With Transient Ischemic Attack. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event

An interventional study of Physical activation on Prescription in Ischemic Attack, Transient, sponsored by Tiohundra AB. Status unknown at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2014-09-16.

Sponsored by Tiohundra AB · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Sep 2014), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 12 studies in Ischemic Attack, Transient with a site in Sweden — none open to participants now, none under way, none of them phase 3. Ischemic Attack, Transient · Sweden.

Planned enrollment
10th of 12
100 · median 1,090
Started
2010
the only one that year
No phase
4 of 12
none open now
Registered
4th of 12
by date
Lead sponsor
1 of 12
Tiohundra AB

Among the 12 studies in Ischemic Attack, Transient with a site in Sweden, this one is the 10th largest by planned enrollment, is the only one that started in 2010, is one of 4 with no phase, and was the 4th registered.

Ischemic Attack, Transient

330 studies on the registry are indexed under Ischemic Attack, Transient; 72 are open to participants now.

Browse Ischemic Attack, Transient studies →

Open to participants now

None of the 12 studies in Ischemic Attack, Transient with a site in Sweden is open now. The open studies under Ischemic Attack, Transient, anywhere →

Who these studies take

Of the 56 Ischemic Attack, Transient studies recruiting now, 38 (68%) set no upper age limit and 6 (11%) stop at 75 or younger; 6 take children under 18; 9 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 12 studies in Ischemic Attack, Transient with a site in Sweden as a file.
02

Study summary

The purpose of this study is to determine whether Physical Activation on Prescription can help patients with TIA to become more physically active.

One group will receives Physical Activation on Prescription (PaP)and the other group will receives usual care.

And to identify if persons with TIA presents with cognitive impairments.

Read the detailed description

Transient ischemic attack (TIA) is a transient episode of neurologic dysfunction caused by ischemia, i.e. loss of blood flow. The symptoms of a TIA typically resolve within 24 hours. Attacks lasting more than 30 minutes are unusual. TIAs and strokes present with the same symptoms such as sudden weakness, numbness, sudden dimming or loss of vision, aphasia, slurred speech, facial palsy and mental impairments. Subtle problems with cognitive functions and fatigue may not always be addressed before discharge. However, even subtle mental impairments are important to identify, given the problems they might pose.

03

Conditions studied

  • Ischemic Attack, Transient

Keywords

  • Walking capacity
  • Mental Fatigue
  • Quality of Life
  • Cognition
  • Motor activity
  • Exercise
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Understand Swedish language (also in and writing), living in Norrtälje community,
  • To participate in the assessment of cognitive function: no known cognitive impairments before the event and history of stroke.

Exclusion criteria

Exclusion Criteria:

  • Presence of to exercise, and no history of stroke
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Physical activity on Prescription (PaP)

    Intervention group receives a PaP for 12 month.

    Other: Physical activation on Prescription

  • No intervention
    Control Group

    The control group has the same monitoring as the experimental group but receives no PaP.

  • No intervention
    Cognitiv function in patients with TIA

    Before discharged from hospital cognitive function is assessed. At the first visit the patients fill in a self assessment questionnaire for mental fatigue. If impaired at the previous assessment cognitive function will be assessed at 3, 6 and 12 month.

  • No intervention
    Controlgroup Cognitive function

    In order to determine whether hospitalization in itself is associated with transient impaired cognition, a comparison group will be included. The comparison group will consist of patients with angina pectoris consecutively admitted to the Norrtälje Hospital. The patients with angina pectoris will be age and sex matched with the patients with TIA and assessed for cognitive function when their angina symptoms have subsided.

Interventions

  • OtherPhysical activation on Prescription

    The advice on physical activity is patient oriented and based on FYSS (FYSS is a information bank that summarizes the up-to-date scientific knowledge on how to prevent and treat various diseases and conditions using physical activity). An individual prescription on physical activity is issued. The prescription form reminds of an ordinary drug prescription and provides specified types of physical activities including intensity, frequency and duration of the respective activities. The prescribed physical activity could be either self-monitored or organized by public physical activity organizations.

    Also known as: PaP

06

What researchers measure

Primary outcomes

  1. Change in Physical activity over time

    Physical activity measured with accelerometer (Time frame: Baseline, 3, 6, and 12 month).

    Time frame: at discharge from hospital, 3, 6 and 12 month after the event

Secondary outcomes

  1. Change in Cognition and Mental Fatigue

    Change in mental conditions over time measured with self report of mental fatigue and related symptoms. This is a scale with 7 different steps for graduate mental fatigue. Less points indicate less mental fatigue.

    Time frame: All measures at baseline 3, 6 and 12 month after the event

  2. Change in 6 MWT

    Change in Walking endurance measured in 3, 6, 12 month measured with 6 MWT (six minutes Walking Test).

    Time frame: 3, 6 and 12 months

  3. Change in self reported stages of change

    A self reported questionnaire that measures willingness to changes in physical activity over time. The scale has different levels of willingness for changes in physical activity.

    Time frame: 3, 6, 12 months

  4. Change from baseline in systolic blood pressure at 12 months

    Time frame: 3, 6, 12 months

  5. BMI

    Body Mass Index is measured at the start and at the end of the study

    Time frame: 12 months

  6. Change in mental capacity over a period of time

    Change in mental capacity measured with a assessment called Cognistat that indicates four different levels of mental capacity.

    Time frame: 3, 6,12 months

  7. Change in mental capacity over a period of time

    Change in mental capacity measured with a assessment called Cognistat that indicates four different levels of mental capacity.

    Time frame: 3, 6, 12 months

07

Study locations

1 site
  • Tiohundra
    Norrtälje, Stockholms Läns Landsting 76192, Sweden
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2010, a primary completion of Apr 2015 and a completion of Jul 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 7, 2011
First posted
Jan 13, 2012
Start
May 2010
Primary completionEst.
Apr 2015
CompletionEst.
Jul 2015
Last update
Sep 16, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01509924
Lead sponsor
Tiohundra AB
Responsible party
Carina Moren (Principal Investigator, Tiohundra AB) — Principal investigator
First posted
Jan 13, 2012
Start date
May 2010
Primary completion
Apr 2015 (estimated)
Completion
Jul 2015 (estimated)
Last update
Sep 16, 2014

Study contacts

Disa Sommerfeld
study director · Karolinska Institutet

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion